Tus kws kho mob
P37-16 Addition of a Drug (Epclusa) to the Hepatitis C Second Generation Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 03, 2016
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2651 - 2660 ntawm 4303
Tus kws kho mob
P24-17 AOR No Longer Required for Submission of Organization Determinations for Platinum Blue Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 18, 2017
Tus kws kho mob
P11R1-17 Revised: Pre-Admission Notification Requirement for Admissions effective June 1, 2017
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 08, 2017
Tus kws kho mob
P12-16 Medicaid Claims Handling for Out of State Medicaid Members
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 26, 2016
Tus kws kho mob
P27R1-16 Revised: Changes to Prior Authorization Requirements for Select Services for Commercial Products
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2016
Tus kws kho mob
P19-17 American Indian Tribal Fee Schedule for Eligible Facility Services Provided to Purchased/Referred Care (PRC) -Eligible American Indians
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 03, 2017
Tus kws kho mob
P25-16 Update to Attachment B: Definition of Outpatient Health Services Categories
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 06, 2016
Tus kws kho mob
P56-16 A New Drug, Dupilumab Will Require Prior Authorization
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 22, 2016
Tus kws kho mob
P4-17 Addition of Drug to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 30, 2017
Tus kws kho mob
P34-16 New Drug-Related Prior Authorization Criteria for Hyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Channel Blocker Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 27, 2016